Colgate-Palmolive India: The company reported largely flat Q4 net profit at ₹353.3 crore due to GST-related inverted duty structure charges, income-tax refund adjustments, and restructuring costs. Excluding exceptional items, net profit grew 9 percent during the quarter.
Lupin: The pharma major announced that China’s National Medical Products Administration has approved its abbreviated new drug application for Oseltamivir Phosphate in partnership with Yabao Pharmaceuticals, marking Lupin’s first entry into the Chinese market.
Aurobindo Pharma: The USFDA has classified Eugia Pharma Specialities’ Unit-I formulation manufacturing facility in Telangana as “Official Action Indicated” (OAI) following an inspection conducted between February 16 and February 27, 2026, which concluded with four observations.
Camlin Fine Sciences: Due to geopolitical tensions and adverse economic conditions impacting raw material availability and pricing, the company has reduced capacity utilisation at its diphenol plant in Dahej SEZ-II, Gujarat, and initiated steps toward shutting down the facility.
FTSE Russell: FTSE has announced the inclusion of Tata Capital, Lenskart Solutions, LG Electronics India, Meesho, ICICI Prudential Asset Management Company, and Billionbrains Garage Ventures (Groww) in its FTSE All World and FTSE All Cap indices, effective June 22.
National Stock Exchange of India: NSE has decided to remove Exide Industries and Nuvama Wealth Management from the Futures & Options segment effective July 29.
TVS Motor Company and Adani Enterprises: TVS Motor Company will replace Adani Enterprises in the Sensex 50 index. Meanwhile, Adani Enterprises, Ashok Leyland, One 97 Communications, and CG Power and Industrial Solutions will be added to the BSE Sensex Next 50 index.
Gujarat Themis Biosyn: The company has signed a definitive agreement to acquire 100 percent stake in MicroBiopharm Japan from funds managed by T Capital Partners in a deal valued at ₹1,300 crore.
Lemon Tree Hotels: The Competition Commission of India has approved the acquisition of certain equity shares of Fleur Hotels by Coastal Cedar Investments BV along with the internal restructuring of the Lemon Tree Hotels group.
RBL Bank: Emirates NBD Bank has announced an open offer to acquire up to 41.55 crore shares, representing 26 percent of RBL Bank’s expanded voting share capital, at ₹282.38 per share. The total offer size stands at ₹11,735.3 crore.
Glenmark Pharmaceuticals: The company’s subsidiary, Glenmark USA, has agreed to a settlement with state attorneys general worth $29.628 million, payable over five years, subject to court approval.
BULK DEALS & BLOCK DEALS
One 97 Communications (Paytm): Elevation Capital and its entities — SAIF III Mauritius Company and SAIF Partners India IV — sold 85.98 lakh shares (1.34 percent stake) worth ₹963.6 crore.
JSW Cement: AP Asia Opportunistic Holdings Pte sold 4.58 crore shares, representing a 3.36 percent stake, for ₹568.14 crore.
Pine Labs: Madison India Opportunities IV sold 2.47 crore shares, representing a 2.15 percent stake, for ₹356.86 crore.
Le Travenues Technology (Ixigo): Schroder International Selection Fund Asian Total Return sold 34.55 lakh shares, representing a 0.78 percent stake, worth ₹58.89 crore at ₹170.42 per share.
PNGS Reva Diamond Jewellery: Baring Private Equity India Fund 6 acquired 2.13 lakh shares (0.67 percent stake) worth ₹8.33 crore at ₹390 per share.
Inventurus Knowledge Solutions: Berjis Minoo Desai sold 6 lakh shares, representing a 0.34 percent stake, for ₹94.8 crore.
Adani Energy Solutions: Birla Mutual Fund acquired 48.05 lakh shares (0.4 percent stake) from Qatar Holding LLC for ₹643.5 crore at ₹1,339 per share.
MAJOR RESULTS TODAY
Wipro Announces ₹15,000 Crore Share Buyback: Record Date Fixed for June 5, 2026
Wipro Limited (NSE: WIPRO ) has officially announced Friday, June 5, 2026, as the Record Date for its upcoming mega equity share buyback program.
Following prior approvals from its Board of Directors and shareholders, the IT heavyweight is set to repurchase up to 60 crore (600,000,000) fully paid-up equity shares (face value of ₹2/- each).